{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:32:18Z","timestamp":1783398738518,"version":"3.54.6"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100008463","name":"Universitas Airlangga","doi-asserted-by":"publisher","award":["1714\/B\/UN3.LPPM\/PT.01.03\/2025"],"award-info":[{"award-number":["1714\/B\/UN3.LPPM\/PT.01.03\/2025"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100008463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"DOI":"10.1007\/s10856-026-07021-6","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:46:36Z","timestamp":1772232396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of niosome formation with chitosan coating on the stability and absorption of orally administered vesicular ursolic acid"],"prefix":"10.1007","volume":"37","author":[{"given":"Devy Maulidya","family":"Cahyani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paskalis Yosna","family":"Piyambudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Retno","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asri","family":"Darmawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berlian Sarasitha","family":"Hariawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qonita Kurnia","family":"Anjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esti","family":"Hendradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1658-0778","authenticated-orcid":false,"given":"Andang","family":"Miatmoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"7021_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.6004\/jnccn.2018.7098","volume":"17","author":"JM Jacobs","year":"2019","unstructured":"Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbein JN, MacDonald JJ, et al. Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. J Natl Compr Cancer Netw. 2019;17:221\u20138.","journal-title":"J Natl Compr Cancer Netw"},{"key":"7021_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ejpb.2016.11.034","volume":"112","author":"AY Abuhelwa","year":"2017","unstructured":"Abuhelwa AY, Williams DB, Upton RN, Foster DJRFood. gastrointestinal pH, and models of oral drug absorption. Eur J Pharm Biopharm. 2017;112:234\u201348. https:\/\/doi.org\/10.1016\/j.ejpb.2016.11.034","journal-title":"Eur J Pharm Biopharm"},{"key":"7021_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/nnm.11.7","volume":"6","author":"SS Feng","year":"2011","unstructured":"Feng SS, Zhao L, Tang J. Nanomedicine for oral chemotherapy. Nanomedicine. 2011;6:407\u201310.","journal-title":"Nanomedicine."},{"key":"7021_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07404-0","volume":"20","author":"Q Peng","year":"2020","unstructured":"Peng Q, Wu W. Development and validation of oral chemotherapy self-management scale. BMC Cancer. 2020;20:890.","journal-title":"BMC Cancer"},{"key":"7021_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/10408347.2017.1390425","volume":"48","author":"AM Pironi","year":"2018","unstructured":"Pironi AM, Ara\u00fajo PR, De, Fernandes MA. Characteristics, biological properties and analytical methods of ursolic acid: a review. Crit Rev Anal Chem. 2018;48:86\u201393.","journal-title":"Crit Rev Anal Chem"},{"key":"7021_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.foodres.2017.10.028","volume":"103","author":"L L\u00f3pez-hortas","year":"2018","unstructured":"L\u00f3pez-hortas L, P\u00e9rez-larr\u00e1n P, Gonz\u00e1lez-mu\u00f1oz MJ, Falqu\u00e9 E, Dom\u00ednguez H. Recent developments on the extraction and application of ursolic acid. A review. Food Res Int. 2018;103:130\u201349. https:\/\/doi.org\/10.1016\/j.foodres.2017.10.028","journal-title":"Food Res Int"},{"key":"7021_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/10408398.2016.1203755","volume":"58","author":"R Yin","year":"2018","unstructured":"Yin R, Li T, Tian J, Xi P, Liu RH. Ursolic acid, a potential anticancer compound for breast cancer therapy. Crit Rev Food Sci Nutr. 2018;58:568\u201374.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"7021_CR8","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.1021\/jf100574j","volume":"58","author":"MH Shyu","year":"2010","unstructured":"Shyu MH, Kao TC, Yen GC. Oleanolic acid and ursolic acid induce apoptosis in Huh7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. J Agric Food Chem. 2010;58:6110\u20138.","journal-title":"J Agric Food Chem"},{"key":"7021_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.xphs.2020.10.006","volume":"110","author":"C Ren","year":"2021","unstructured":"Ren C, Kong D, Ning C, Xing H, Cheng Y, Zhang Y, et al. Improved pharmacokinetic characteristics of ursolic acid in rats following intratracheal instillation and nose-only inhalation exposure. J Pharm Sci. 2021;110:905\u201313. https:\/\/doi.org\/10.1016\/j.xphs.2020.10.006","journal-title":"J Pharm Sci"},{"key":"7021_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.biopha.2018.09.096","volume":"108","author":"J Iqbal","year":"2018","unstructured":"Iqbal J, Abbasi BA, Ahmad R, Mahmood T, Kanwal S, Ali B, et al. Ursolic acid, a promising candidate in the therapeutics of breast cancer: Current status and future implications. Biomed Pharmacother. 2018;108:752\u20136. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.096","journal-title":"Biomed Pharmacother"},{"key":"7021_CR11","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.bcp.2013.03.006","volume":"85","author":"MK Shanmugam","year":"2013","unstructured":"Shanmugam MK, Dai X, Kumar AP, Tan BKH, Sethi G, Bishayee A. Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. Biochem Pharm. 2013;85:1579\u20131587. https:\/\/doi.org\/10.1016\/j.bcp.2013.03.006","journal-title":"Biochem Pharm"},{"key":"7021_CR12","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/molecules24152751","volume":"24","author":"S Mlala","year":"2019","unstructured":"Mlala S, Oyedeji AO, Gondwe M, Oyedeji OO. Ursolic acid and its derivatives as bioactive agents. Molecules. 2019;24:2751.","journal-title":"Molecules."},{"key":"7021_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/pharmaceutics12030264","volume":"12","author":"MK Lee","year":"2020","unstructured":"Lee MK. Liposomes for enhanced bioavailability of water-insoluble drugs: in vivo evidence and recent approaches. Pharmaceutics. 2020;12:264.","journal-title":"Pharmaceutics."},{"key":"7021_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","volume":"9","author":"H He","year":"2019","unstructured":"He H, Lu Y, Qi J, Zhu Q, Chen Z, Wu W. Adapting liposomes for oral drug delivery. Acta Pharm Sin B. 2019;9:36\u201348.","journal-title":"Acta Pharm Sin B."},{"key":"7021_CR15","doi-asserted-by":"publisher","first-page":"9668","DOI":"10.3390\/ijms23179668","volume":"23","author":"BA Witika","year":"2022","unstructured":"Witika BA, Bassey KE, Demana PH, Siwe-Noundou X, Poka MS. Current advances in specialised niosomal drug delivery: Manufacture, characterization and drug delivery applications. Int J Mol Sci. 2022;23:9668.","journal-title":"Int J Mol Sci"},{"key":"7021_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cis.2012.08.002","volume":"183\u2013184","author":"NB Mahale","year":"2012","unstructured":"Mahale NB, Thakkar PD, Walunj DR, Chaudhari SR. Niosomes: novel sustained release nonionic stable vesicular systems\u2014an overview. Adv Colloid Interface Sci. 2012;183\u2013184:46\u201354. https:\/\/doi.org\/10.1016\/j.cis.2012.08.002","journal-title":"Adv Colloid Interface Sci"},{"key":"7021_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","volume":"1","author":"GP Kumar","year":"2011","unstructured":"Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery\u2014an overview. Acta Pharm Sin B. 2011;1:208\u201319. https:\/\/doi.org\/10.1016\/j.apsb.2011.09.002","journal-title":"Acta Pharm Sin B."},{"key":"7021_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","volume":"185","author":"S Moghassemi","year":"2014","unstructured":"Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22\u201336. https:\/\/doi.org\/10.1016\/j.jconrel.2014.04.015","journal-title":"J Control Release"},{"key":"7021_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/0110-5558.76435","volume":"1","author":"K Karim","year":"2010","unstructured":"Karim K, Mandal A, Biswas N, Guha A, Chatterjee S, Behera M, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1:374\u201380.","journal-title":"J Adv Pharm Technol Res"},{"key":"7021_CR20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/pharmaceutics14061147","volume":"14","author":"HM Hnin","year":"2022","unstructured":"Hnin HM, Stef\u00e1nsson E, Loftsson T, Asasutjarit R, Charnvanich D, Jansook P. Physicochemical and stability evaluation of topical niosomal encapsulating fosinopril\/\u03b3-cyclodextrin complex for ocular delivery. Pharmaceutics. 2022;14:1147.","journal-title":"Pharmaceutics."},{"key":"7021_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.22159\/ijap.2021v13i2.40423","volume":"13","author":"G Sawant","year":"2021","unstructured":"Sawant G, Bhagwat G. Niosomes as an approach to improve the solubility and bioavailability of BCS Class II drugs. Int J Appl Pharm. 2021;13:94\u2013101.","journal-title":"Int J Appl Pharm"},{"key":"7021_CR22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1208\/s12249-010-9480-2","volume":"11","author":"K Ruckmani","year":"2010","unstructured":"Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech. 2010;11:1119\u201327.","journal-title":"AAPS PharmSciTech"},{"key":"7021_CR23","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1208\/s12249-009-9325-z","volume":"10","author":"PS Jadon","year":"2009","unstructured":"Jadon PS, Gajbhiye V, Jadon RS, Gajbhiye KR, Ganesh N. Enhanced Oral bioavailability of griseofulvin via niosomes research article enhanced oral bioavailability of griseofulvin via niosomes. AAPS PharmSciTech. 2009;10:1186\u201392.","journal-title":"AAPS PharmSciTech"},{"key":"7021_CR24","doi-asserted-by":"publisher","first-page":"7372306","DOI":"10.1155\/2016\/7372306","volume":"2016","author":"DA Seleci","year":"2016","unstructured":"Seleci DA, Seleci M, Walter JG, Stahl F, Scheper T. Niosomes as nanoparticular drug carriers: Fundamentals and recent applications. J Nanomater. 2016;2016:7372306.","journal-title":"J Nanomater"},{"key":"7021_CR25","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.4155\/tde.15.69","volume":"6","author":"W Wu","year":"2015","unstructured":"Wu W, Lu Y, Qi J. Oral delivery of liposomes. Ther Deliv. 2015;6:1239\u201341.","journal-title":"Ther Deliv"},{"key":"7021_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.foodchem.2014.11.108","volume":"175","author":"W Liu","year":"2015","unstructured":"Liu W, Ye A, Liu W, Liu C, Han J, Singh H. Behaviour of liposomes loaded with bovine serum albumin during in vitro digestion. Food Chem. 2015;175:16\u201324. https:\/\/doi.org\/10.1016\/j.foodchem.2014.11.108","journal-title":"Food Chem"},{"key":"7021_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/pharmaceutics14061128","volume":"14","author":"H Alrbyawi","year":"2022","unstructured":"Alrbyawi H, Poudel I, Annaji M, Boddu SHS, Arnold RD, Tiwari AK, et al. pH-Sensitive liposomes for enhanced cellular uptake and cytotoxicity of daunorubicin in melanoma (B16-BL6) cell lines. Pharmaceutics. 2022;14:1128.","journal-title":"Pharmaceutics."},{"key":"7021_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bpg.2016.02.007","volume":"30","author":"PR Kiela","year":"2016","unstructured":"Kiela PR, Ghishan FK. Physiology of intestinal absorption and secretion. Best Pract Res Clin Gastroenterol. 2016;30:145\u201359.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"7021_CR29","doi-asserted-by":"publisher","first-page":"105280.","DOI":"10.1016\/j.ejps.2020.105280","volume":"147","author":"C Stillhart","year":"2020","unstructured":"Stillhart C, Vu\u010di\u0107evi\u0107 K, Augustijns P, Basit AW, Batchelor H, Flanagan TR, et al. Impact of gastrointestinal physiology on drug absorption in special populations\u2013an UNGAP review. Eur J Pharm Sci. 2020;147:105280. https:\/\/doi.org\/10.1016\/j.ejps.2020.105280","journal-title":"Eur J Pharm Sci"},{"key":"7021_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.17533\/udea.rccp.v31n1a01","volume":"31","author":"M Itza-Ortiz","year":"2018","unstructured":"Itza-Ortiz M, Quezada-Casasola A, Castillo-Castillo Y, Rodr\u00edguez-Galindo E, Carrera-Ch\u00e1vez JM, Mart\u00edn-Orozco U, et al. Comparison of three sampling procedures for evaluating intestinal villi: a swine model. Rev Colomb Cienc Pecu. 2018;31:3\u20139.","journal-title":"Rev Colomb Cienc Pecu"},{"key":"7021_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799\u2013809. https:\/\/doi.org\/10.1038\/nri2653","journal-title":"Nat Rev Immunol"},{"key":"7021_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4155\/tde.10.89","volume":"2","author":"J Richard","year":"2020","unstructured":"Richard J. Challenges and opportunities in the delivery of cancer therapeutics. Ther Deliv. 2020;2:107\u201321.","journal-title":"Ther Deliv"},{"key":"7021_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.addr.2021.02.008","volume":"171","author":"J Brunner","year":"2021","unstructured":"Brunner J, Ragupathy S, Borchard G. Target-specific tight junction modulators. Adv Drug Deliv Rev. 2021;171:266\u201388.","journal-title":"Adv Drug Deliv Rev"},{"key":"7021_CR34","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3390\/md13041819","volume":"13","author":"E Szyma\u0144ska","year":"2015","unstructured":"Szyma\u0144ska E, Winnicka K. Stability of chitosan\u2014a challenge for pharmaceutical and biomedical applications. Mar Drugs. 2015;13:1819\u201346.","journal-title":"Mar Drugs"},{"key":"7021_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/pharmaceutics10020038","volume":"10","author":"F Rinaldi","year":"2018","unstructured":"Rinaldi F, Hanieh PN, Chan LKN, Angeloni L, Passeri D, Rossi M, et al. Chitosan glutamate-coated niosomes: a proposal for nose-to-brain delivery. Pharmaceutics. 2018;10:38.","journal-title":"Pharmaceutics."},{"key":"7021_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/pr9030445","volume":"9","author":"C Sebaaly","year":"2021","unstructured":"Sebaaly C, Trifan A, Sieniawska E, Greige-Gerges H. Chitosan-coating effect on the characteristics of liposomes: a focus on bioactive compounds and essential oils: a review. Processes. 2021;9:445.","journal-title":"Processes"},{"key":"7021_CR37","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1208\/s12249-017-0780-7","volume":"18","author":"AZM Khalifa","year":"2017","unstructured":"Khalifa AZM, Abdul Rasool BK. Optimized mucoadhesive coated niosomes as a sustained oral delivery system of famotidine. AAPS PharmSciTech. 2017;18:3064\u201375.","journal-title":"AAPS PharmSciTech"},{"key":"7021_CR38","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.msec.2016.11.014","volume":"71","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao T, Liu Y, Wang Q, Xing S, Li L, et al. Ursolic acid liposomes with chitosan modification: promising antitumor drug delivery and efficacy. Mater Sci Eng C. 2017;71:1231\u201340. https:\/\/doi.org\/10.1016\/j.msec.2016.11.014","journal-title":"Mater Sci Eng C."},{"key":"7021_CR39","doi-asserted-by":"publisher","first-page":"660","DOI":"10.4103\/1735-5362.327512","volume":"16","author":"A Miatmoko","year":"2021","unstructured":"Miatmoko A, Safitri SA, Aquila F, Cahyani DM, Hariawan BS, Hendrianto E, et al. Characterization and distribution of niosomes containing ursolic acid coated with chitosan layer. Res Pharm Sci. 2021;16:660\u201373.","journal-title":"Res Pharm Sci"},{"key":"7021_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26085-2","volume":"12","author":"A Miatmoko","year":"2022","unstructured":"Miatmoko A, Faradisa AA, Jauhari AA, Hariawan BS, Cahyani DM, Plumeriastuti H, et al. The effectiveness of ursolic acid niosomes with chitosan coating for prevention of liver damage in mice induced by n-nitrosodiethylamine. Sci Rep. 2022;12:21397. https:\/\/doi.org\/10.1038\/s41598-022-26085-2","journal-title":"Sci Rep"},{"key":"7021_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejps.2016.12.009","volume":"108","author":"DR Telange","year":"2017","unstructured":"Telange DR, Patil AT, Pethe AM, Fegade H, Anand S, Dave VS. Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential. Eur J Pharm Sci. 2017;108:36\u201349. https:\/\/doi.org\/10.1016\/j.ejps.2016.12.009","journal-title":"Eur J Pharm Sci"},{"key":"7021_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4155\/tde-2019-0015","volume":"10","author":"N Rosita","year":"2019","unstructured":"Rosita N, Meitasari VA, Rianti MC, Hariyadi DM, Miatmoko A. Enhancing skin penetration of epigallocatechin gallate by modifying partition coefficient using reverse micelle method. Ther Deliv. 2019;10:409\u201317.","journal-title":"Ther Deliv"},{"key":"7021_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijpharm.2017.12.044","volume":"537","author":"Y Liu","year":"2018","unstructured":"Liu Y, Yang T, Wei S, Zhou C, Lan Y, Cao A, et al. Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery. Int J Pharm. 2018;537:245\u201356. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.12.044","journal-title":"Int J Pharm"},{"key":"7021_CR44","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1016\/j.vaccine.2011.05.015","volume":"29","author":"Z Li","year":"2011","unstructured":"Li Z, Zhang L, Sun W, Ding Q, Hou Y, Xu Y. Archaeosomes with encapsulated antigens for oral vaccine delivery. Vaccine. 2011;29:5260\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.015","journal-title":"Vaccine."},{"key":"7021_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.20473\/jfiki.v10i12023.54-61","volume":"10","author":"E Hendradi","year":"2023","unstructured":"Hendradi E, Rahayuningtyas, Erawati T. The effect of polymers the ratio carboxymethyl chitosan, polyvinyl pyrolidone k-30, and ethyl cellulose n22 on physico-chemical characteristics and drug release from matrix-type diclofenac potassium patch. J Farm Ilmu Kefarmasian Indones. 2023;10:54\u201361.","journal-title":"J Farm Ilmu Kefarmasian Indones"},{"key":"7021_CR46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1515\/jbcpp-2020-0475","volume":"32","author":"DM Cahyani","year":"2021","unstructured":"Cahyani DM, Miatmoko A, Hariawan BS, Purwantari KE, Sari R. N-nitrosodiethylamine induces inflammation of liver in mice. J Basic Clin Physiol Pharm. 2021;32:505\u201310.","journal-title":"J Basic Clin Physiol Pharm"},{"key":"7021_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1248\/yakushi.125.509","volume":"125","author":"Q Liao","year":"2005","unstructured":"Liao Q, Yang W, Jia Y, Chen X, Gao Q, Bi K. LC-MS Determination and pharmacokinetic studies of ursolic acid in rat plasma after administration of the traditional chinese medicinal preparation Lu-ying extract. Yakugaku Zasshi. 2005;125:509\u201315.","journal-title":"Yakugaku Zasshi"},{"key":"7021_CR48","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s11094-020-02231-w","volume":"54","author":"NA Epshtein","year":"2020","unstructured":"Epshtein NA. System suitability requirements for liquid chromatography methods: controlled parameters and their recommended values (review). Pharm Chem J. 2020;54:518\u201325.","journal-title":"Pharm Chem J."},{"key":"7021_CR49","unstructured":"USP. Chromatography <621>. United States Pharmacopeia - National Formulary. 2022. https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/harmonization\/gen-chapter\/harmonization-november-2021-m99380.pdf. Accessed 24 Feb 2026."},{"key":"7021_CR50","first-page":"1217","volume":"31","author":"MM de Almeida","year":"2012","unstructured":"de Almeida MM, Bou-Chacra NA, Tavares VF, Baby AR, Kaneko TM, Velasco MVR. Determination of ursolic acid from polymeric nanoparticles using a high-performance liquid chromatography method. Lat Am J Pharm. 2012;31:1217\u201321.","journal-title":"Lat Am J Pharm"},{"key":"7021_CR51","unstructured":"ICH. ICH Harmonised tripartite guideline - Validation of analytical procedures: Text and Methodology Q2(R1). 2005. https:\/\/database.ich.org\/sites\/default\/files\/Q2%28R1%29%20Guideline.pdf. Accessed 24 Feb 2026."},{"key":"7021_CR52","unstructured":"European Medicines Agency. ICH guideline M10 on bioanalytical method validation and study sample analysis: Step 5. European Medicines Agency. 2022;1\u201323. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf. Accessed 24 Feb 2026."},{"key":"7021_CR53","unstructured":"AOAC. International Official Methods of Analysis of AOAC International. 18th Edition. Gaithersburg: AOAC International; 2005."},{"key":"7021_CR54","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0099-5428(05)32009-0","volume":"32","author":"M Yuwono","year":"2005","unstructured":"Yuwono M, Indrayanto G. Validation of chromatographic methods of analysis. Profiles Drug Subst Excip Relat Methodol. 2005;32:243\u201359.","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"7021_CR55","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1021\/acs.iecr.9b00504","volume":"58","author":"F Goodarzi","year":"2019","unstructured":"Goodarzi F, Zendehboudi S. Effects of salt and surfactant on interfacial characteristics of water\/oil systems: molecular dynamic simulations and dissipative particle dynamics. Ind Eng Chem Res. 2019;58:8817\u201334.","journal-title":"Ind Eng Chem Res"},{"key":"7021_CR56","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/pharmaceutics15020380","volume":"15","author":"C Butnarasu","year":"2023","unstructured":"Butnarasu C, Garbero OV, Petrini P, Visai L, Visentin S. Permeability Assessment of a high-throughput mucosal platform. Pharmaceutics. 2023;15:380.","journal-title":"Pharmaceutics."},{"key":"7021_CR57","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrd3187","volume":"9","author":"K Sugano","year":"2010","unstructured":"Sugano K, Kansy M, Artursson P, Avdeef A, Bendels S, Di L, et al. Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov. 2010;9:597\u2013614.","journal-title":"Nat Rev Drug Discov"},{"key":"7021_CR58","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ejps.2019.04.020","volume":"134","author":"Y Lee","year":"2019","unstructured":"Lee Y, Choi SQ. Quantitative analysis for lipophilic drug transport through a model lipid membrane with membrane retention. Eur J Pharm Sci. 2019;134:176\u201384. https:\/\/doi.org\/10.1016\/j.ejps.2019.04.020","journal-title":"Eur J Pharm Sci"},{"key":"7021_CR59","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/antiox10081161","volume":"10","author":"HN Nguyen","year":"2021","unstructured":"Nguyen HN, Ullevig SL, Short JD, Wang L, Ahn YJ, Asmis R. Ursolic acid and related analogues: triterpenoids with broad health benefits. Antioxidants. 2021;10:1161.","journal-title":"Antioxidants."},{"key":"7021_CR60","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1021\/acs.molpharmaceut.0c00443","volume":"17","author":"D Yu","year":"2020","unstructured":"Yu D, Kan Z, Shan F, Zang J, Zhou J. Triple strategies to improve oral bioavailability by fabricating coamorphous forms of ursolic acid with piperine: enhancing water-solubility, permeability, and inhibiting cytochrome p450 isozymes. Mol Pharm. 2020;17:4443\u201362.","journal-title":"Mol Pharm"},{"key":"7021_CR61","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0006-3495(99)77363-7","volume":"76","author":"S Raffy","year":"1999","unstructured":"Raffy S, Teissi\u00e9 J. Control of lipid membrane stability by cholesterol content. Biophys J. 1999;76:2072\u201380.","journal-title":"Biophys J"},{"key":"7021_CR62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","volume":"58","author":"RN Gursoy","year":"2004","unstructured":"Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173\u201382.","journal-title":"Biomed Pharmacother"},{"key":"7021_CR63","doi-asserted-by":"publisher","first-page":"E106","DOI":"10.1208\/pt0804106","volume":"8","author":"IA Attia","year":"2007","unstructured":"Attia IA, El-gizawy SA, Fouda MA, Donia AM. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech. 2007;8:E106.","journal-title":"AAPS PharmSciTech"},{"key":"7021_CR64","doi-asserted-by":"publisher","first-page":"e1361900","DOI":"10.1080\/21688370.2017.1361900","volume":"5","author":"EM Danielsen","year":"2017","unstructured":"Danielsen EM, Hansen GH. Intestinal surfactant permeation enhancers and their interaction with enterocyte cell membranes in a mucosal explant system. Tissue Barriers. 2017;5:e1361900.","journal-title":"Tissue Barriers"},{"key":"7021_CR65","doi-asserted-by":"publisher","first-page":"122022.","DOI":"10.1016\/j.ijpharm.2022.122022","volume":"624","author":"VGS Sainaga Jyothi","year":"2022","unstructured":"Sainaga Jyothi VGS, Bulusu R, Venkata Krishna Rao B, Pranothi M, Banda S, Kumar Bolla P, et al. Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: an update. Int J Pharm. 2022;624:122022. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122022","journal-title":"Int J Pharm"},{"key":"7021_CR66","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.biochi.2013.07.006","volume":"95","author":"B Maherani","year":"2013","unstructured":"Maherani B, Arab-Tehrany E, Kheirolomoom A, Geny D, Linder M. Calcein release behavior from liposomal bilayer; Influence of physicochemical\/mechanical\/structural properties of lipids. Biochimie. 2013;95:2018\u201333. https:\/\/doi.org\/10.1016\/j.biochi.2013.07.006","journal-title":"Biochimie."},{"key":"7021_CR67","doi-asserted-by":"publisher","first-page":"163.","DOI":"10.1208\/s12249-022-02308-7","volume":"23","author":"C Guo","year":"2022","unstructured":"Guo C, Zhu X, Yuan H, Liu H, Zhang Y, Yin T, et al. Chitosan-coated liposomes: the strategy to reduce intestinal toxicity and improve bioavailability of oral vinorelbine. AAPS PharmSciTech. 2022;23:163. https:\/\/doi.org\/10.1208\/s12249-022-02308-7","journal-title":"AAPS PharmSciTech"},{"key":"7021_CR68","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/03639045.2013.858740","volume":"41","author":"C Liu","year":"2015","unstructured":"Liu C, Shi J, Dai Q, Yin X, Zhang X, Zheng A. In-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration. Drug Dev Ind Pharm. 2015;41:272\u20138.","journal-title":"Drug Dev Ind Pharm"},{"key":"7021_CR69","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1021\/acsomega.2c06752","volume":"8","author":"M Wang","year":"2022","unstructured":"Wang M, Yang L, Zhu X, Yang L, Song Z. Influence of enzymes on the in vitro degradation behavior of pure zn in simulated gastric and intestinal fluids. ACS Omega. 2022;8:1331\u20131342.","journal-title":"ACS Omega"},{"key":"7021_CR70","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/md20030156","volume":"20","author":"MK Amin","year":"2022","unstructured":"Amin MK, Boateng JS. Enhancing stability and mucoadhesive properties of chitosan nanoparticles by surface modification with sodium alginate and polyethylene glycol for potential oral mucosa vaccine delivery. Mar Drugs. 2022;20:156.","journal-title":"Mar Drugs"},{"key":"7021_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00979-1","volume":"19","author":"Y Chen","year":"2021","unstructured":"Chen Y, Jiang Z, Xu J, Zhang J, Sun R, Zhou J, et al. Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcoholic fatty liver disease in mice. J Nanobiotechnology. 2021;19:230. https:\/\/doi.org\/10.1186\/s12951-021-00979-1","journal-title":"J Nanobiotechnology"},{"key":"7021_CR72","doi-asserted-by":"publisher","first-page":"100837.","DOI":"10.1016\/j.mtbio.2023.100837","volume":"23","author":"A Moammeri","year":"2023","unstructured":"Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, et al. Current advances in niosome applications for drug delivery and cancer treatment. Mater Today Bio. 2023;23:100837. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100837","journal-title":"Mater Today Bio"},{"key":"7021_CR73","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijbiomac.2021.01.041","volume":"172","author":"E Antonio","year":"2021","unstructured":"Antonio E, dos Reis Antunes Junior O, Marcano RGDJV, Diedrich C, da Silva Santos J, et al. Chitosan-modified poly (lactic acid) nanoparticles increased the ursolic acid oral bioavailability. Int J Biol Macromol. 2021;172:133\u201342. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.041","journal-title":"Int J Biol Macromol"},{"key":"7021_CR74","doi-asserted-by":"publisher","first-page":"e08674.","DOI":"10.1016\/j.heliyon.2021.e08674","volume":"8","author":"Y Herdiana","year":"2022","unstructured":"Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Drug release study of the chitosan-based nanoparticles. Heliyon. 2022;8:e08674. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08674","journal-title":"Heliyon."},{"key":"7021_CR75","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijbiomac.2020.04.233","volume":"158","author":"AJ Coutinho","year":"2020","unstructured":"Coutinho AJ, Costa Lima SA, Afonso CMM, Reis S. Mucoadhesive and pH-responsive fucoidan-chitosan nanoparticles for the oral delivery of methotrexate. Int J Biol Macromol. 2020;158:180\u20138.","journal-title":"Int J Biol Macromol"},{"key":"7021_CR76","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fphar.2020.00524","volume":"11","author":"S Hua","year":"2020","unstructured":"Hua S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract\u2014influence of physiological, pathophysiological and pharmaceutical factors. Front Pharmacol. 2020;11:524.","journal-title":"Front Pharmacol"},{"key":"7021_CR77","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1080\/17460441.2017.1378176","volume":"12","author":"T Murakami","year":"2017","unstructured":"Murakami T. Absorption sites of orally administered drugs in the small intestine. Expert Opin Drug Discov. 2017;12:1219\u201332. https:\/\/doi.org\/10.1080\/17460441.2017.1378176","journal-title":"Expert Opin Drug Discov"},{"key":"7021_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13068-015-0220-4","volume":"8","author":"J Rumin","year":"2015","unstructured":"Rumin J, Bonnefond H, Saint-Jean B, Rouxel C, Sciandra A, Bernard O, et al. The use of fluorescent Nile red and BODIPY for lipid measurement in microalgae. Biotechnol Biofuels. 2015;8:42.","journal-title":"Biotechnol Biofuels"},{"key":"7021_CR79","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/polym15040793","volume":"15","author":"K Piekarska","year":"2023","unstructured":"Piekarska K, Sikora M, Owczarek M, J\u00f3\u017awik-Pruska J, Wi\u015bniewska-Wrona M. Chitin and chitosan as polymers of the future\u2014obtaining, modification, life cycle assessment and main directions of application. Polymers. 2023;15:793.","journal-title":"Polymers."},{"key":"7021_CR80","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.msec.2016.11.014","volume":"71","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao T, Liu Y, Wang Q, Xing S, Li L, et al. Ursolic acid liposomes with chitosan modification: promising antitumor drug delivery and efficacy. Mater Sci Eng C. 2017;71:1231\u201340.","journal-title":"Mater Sci Eng C."},{"key":"7021_CR81","doi-asserted-by":"publisher","first-page":"121382.","DOI":"10.1016\/j.ijpharm.2021.121382","volume":"612","author":"P Joyce","year":"2022","unstructured":"Joyce P, Wignall A, Peressin K, Wright L, Williams DB, Prestidge CA. Chitosan nanoparticles facilitate improved intestinal permeation and oral pharmacokinetics of the mast cell stabiliser cromoglycate. Int J Pharm. 2022;612:121382. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121382","journal-title":"Int J Pharm"},{"key":"7021_CR82","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.1016\/j.biomaterials.2011.03.056","volume":"32","author":"TH Yeh","year":"2011","unstructured":"Yeh TH, Hsu LW, Tseng MT, Lee PL, Sonjae K, Ho YC, et al. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials. 2011;32:6164\u201373. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.03.056","journal-title":"Biomaterials."},{"key":"7021_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","volume":"21","author":"J Smith","year":"2004","unstructured":"Smith J, Wood E, Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm Res. 2004;21:43\u20139.","journal-title":"Pharm Res"},{"key":"7021_CR84","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/pharmaceutics11020055","volume":"11","author":"X Ge","year":"2019","unstructured":"Ge X, Wei M, He S, Yuan WE. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics. 2019;11:55.","journal-title":"Pharmaceutics."},{"key":"7021_CR85","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1208\/s12249-010-9432-x","volume":"11","author":"X Li","year":"2010","unstructured":"Li X, Yuan Q, Huang Y, Zhou Y, Liu Y. Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability. AAPS PharmSciTech. 2010;11:672\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"7021_CR86","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","volume":"63","author":"J Fang","year":"2011","unstructured":"Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136\u201351. https:\/\/doi.org\/10.1016\/j.addr.2010.04.009","journal-title":"Adv Drug Deliv Rev"},{"key":"7021_CR87","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1021\/nn900002m","volume":"3","author":"OC Farokhzad","year":"2009","unstructured":"Farokhzad OC, Langer R. Impact of nanotechnology on hair attributes. ACS Nano. 2009;3:16\u201320.","journal-title":"ACS Nano"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-026-07021-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-026-07021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-026-07021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:02:42Z","timestamp":1772607762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10856-026-07021-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7021"],"URL":"https:\/\/doi.org\/10.1007\/s10856-026-07021-6","relation":{},"ISSN":["1573-4838"],"issn-type":[{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}